Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

October 22, 2025

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

November 13, 2024

A Sham-Controlled Trial of AF Ablation Is Feasible, but Is It Needed?

News Features

A Sham-Controlled Trial of AF Ablation Is Feasible, but Is It Needed?

January 25, 2024

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

News Features

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Yael L. Maxwell

December 14, 2023

Cardiologists’ Anger Flares Anew Over ABIM Maintenance of Certification

News Features

Cardiologists’ Anger Flares Anew Over ABIM Maintenance of Certification

July 14, 2023

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

July 07, 2022

As TAVI Turns 20, How Has the Heart Team Evolved?

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

December 09, 2021

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

December 14, 2020

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

News Features

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

May 20, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

May 30, 2019

Top News in Heart Rhythm: 2018

News Features

Top News in Heart Rhythm: 2018

December 28, 2018

Top News in Policy & Practice: 2018

News Features

Top News in Policy & Practice: 2018

December 28, 2018

Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria

News Features

Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria

October 18, 2018

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

May 02, 2018

The Numbers Game: Door-to-Balloon or First Medical Contact? STEMI Care Still Needs Work Nationwide

News Features

The Numbers Game: Door-to-Balloon or First Medical Contact? STEMI Care Still Needs Work Nationwide

March 16, 2017

Trump’s Immigration Order Quickly Hits Home for Some Foreign-Born Physicians

News Features

Trump’s Immigration Order Quickly Hits Home for Some Foreign-Born Physicians

January 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.